Lyell Immunopharma, Inc.
Book Per Share
| Period | Book Per Share | Cash Per Share |
|---|---|---|
| Dec 2020 | $-1.88 | $0.90 |
| Mar 2021 | $-1.93 | $1.41 |
| Jun 2021 | $2.39 | $1.32 |
| Sep 2021 | $0.41 | $0.16 |
| Dec 2021 | $3.83 | $1.21 |
| Mar 2022 | $3.61 | $0.91 |
| Jun 2022 | $3.52 | $0.84 |
| Sep 2022 | $3.30 | $0.47 |
| Dec 2022 | $3.34 | $0.50 |
| Mar 2023 | $3.14 | $0.44 |
| Jun 2023 | $2.95 | $0.90 |
| Sep 2023 | $2.78 | $1.14 |
| Dec 2023 | $2.58 | $0.57 |
| Mar 2024 | $2.37 | $0.49 |
| Jun 2024 | $44.36 | $10.45 |
| Sep 2024 | $41.41 | $7.83 |
| Dec 2024 | $25.97 | $7.16 |
| Mar 2025 | $22.81 | $8.16 |
| Jun 2025 | $20.21 | $6.68 |
| Sep 2025 | $18.02 | $6.76 |
| Dec 2025 | $11.68 | $2.83 |
| Mar 2026 | $12.51 | $4.15 |
| Jun 2026 | $10.01 | $3.12 |